A carregar...
Carrier-free nano-assembly of curcumin-erlotinib conjugate for cancer targeted therapy
Anticancer drug-loaded nanoparticles have been explored extensively to decrease side effects while improving their therapeutic efficacy. However, due to the low drug loading content, premature drug release, non-standardized carrier structure, and difficulty in predicting the fate of the carrier, onl...
Na minha lista:
| Publicado no: | Adv Healthc Mater |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7593849/ https://ncbi.nlm.nih.gov/pubmed/32893507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.202001128 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|